BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 31816634)

  • 1. LncRNA-encoded polypeptide ASRPS inhibits triple-negative breast cancer angiogenesis.
    Wang Y; Wu S; Zhu X; Zhang L; Deng J; Li F; Guo B; Zhang S; Wu R; Zhang Z; Wang K; Lu J; Zhou Y
    J Exp Med; 2020 Mar; 217(3):. PubMed ID: 31816634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA HOST2, working as a competitive endogenous RNA, promotes STAT3-mediated cell proliferation and migration via decoying of let-7b in triple-negative breast cancer.
    Hua K; Deng X; Hu J; Ji C; Yu Y; Li J; Wang X; Fang L
    J Exp Clin Cancer Res; 2020 Apr; 39(1):58. PubMed ID: 32248842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A micropeptide XBP1SBM encoded by lncRNA promotes angiogenesis and metastasis of TNBC via XBP1s pathway.
    Wu S; Guo B; Zhang L; Zhu X; Zhao P; Deng J; Zheng J; Li F; Wang Y; Zhang S; Zhang Z; Lu J; Zhou Y
    Oncogene; 2022 Apr; 41(15):2163-2172. PubMed ID: 35197570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA PTCSC3 inhibits triple-negative breast cancer cell proliferation by downregulating lncRNA H19.
    Wang N; Hou M; Zhan Y; Sheng X
    J Cell Biochem; 2019 Sep; 120(9):15083-15088. PubMed ID: 31026090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA ZFAS1 inhibits triple-negative breast cancer by targeting STAT3.
    Sharma U; Barwal TS; Khandelwal A; Malhotra A; Rana MK; Singh Rana AP; Imyanitov EN; Vasquez KM; Jain A
    Biochimie; 2021 Mar; 182():99-107. PubMed ID: 33429003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC; Wang JX; Han ML; Zhang LP; Li L
    Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA NRON down-regulates lncRNA snaR and inhibits cancer cell proliferation in TNBC.
    Niu L; Fan Q; Yan M; Wang L
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30996114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Wwox drives metastasis in triple-negative breast cancer by JAK2/STAT3 axis.
    Chang R; Song L; Xu Y; Wu Y; Dai C; Wang X; Sun X; Hou Y; Li W; Zhan X; Zhan L
    Nat Commun; 2018 Aug; 9(1):3486. PubMed ID: 30154439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-544 down-regulates both Bcl6 and Stat3 to inhibit tumor growth of human triple negative breast cancer.
    Zhu Z; Wang S; Zhu J; Yang Q; Dong H; Huang J
    Biol Chem; 2016 Oct; 397(10):1087-95. PubMed ID: 27186677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-terminal HSP90 inhibitor L80 elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition.
    Cho TM; Kim JY; Kim YJ; Sung D; Oh E; Jang S; Farrand L; Hoang VH; Nguyen CT; Ann J; Lee J; Seo JH
    Cancer Lett; 2019 Apr; 447():141-153. PubMed ID: 30703411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Triple-Negative Breast Cancer Tumor Growth by Electroacupuncture with Encircled Needling and Its Mechanisms in a Mice Xenograft Model.
    Jiang X; Tian Y; Xu L; Zhang Q; Wan Y; Qi X; Li B; Guo J; Sun W; Luo A; Huang J; Gu X
    Int J Med Sci; 2019; 16(12):1642-1651. PubMed ID: 31839752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SANT, a novel Chinese herbal monomer combination, decreasing tumor growth and angiogenesis via modulating autophagy in heparanase overexpressed triple-negative breast cancer.
    Li QW; Zhang GL; Hao CX; Ma YF; Sun X; Zhang Y; Cao KX; Li BX; Yang GW; Wang XM
    J Ethnopharmacol; 2021 Feb; 266():113430. PubMed ID: 33011366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p.
    Li S; Zhou J; Wang Z; Wang P; Gao X; Wang Y
    Biomed Pharmacother; 2018 Aug; 104():451-457. PubMed ID: 29793177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of long non-coding RNA ENSG00000226738 (LncKLHDC7B) is enriched in the immunomodulatory triple-negative breast cancer subtype and its alteration promotes cell migration, invasion, and resistance to cell death.
    Beltrán-Anaya FO; Romero-Córdoba S; Rebollar-Vega R; Arrieta O; Bautista-Piña V; Dominguez-Reyes C; Villegas-Carlos F; Tenorio-Torres A; Alfaro-Riuz L; Jiménez-Morales S; Cedro-Tanda A; Ríos-Romero M; Reyes-Grajeda JP; Tagliabue E; Iorio MV; Hidalgo-Miranda A
    Mol Oncol; 2019 Apr; 13(4):909-927. PubMed ID: 30648789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA Uc003xsl.1-Mediated Activation of the NFκB/IL8 Axis Promotes Progression of Triple-Negative Breast Cancer.
    Xu Y; Ren W; Li Q; Duan C; Lin X; Bi Z; You K; Hu Q; Xie N; Yu Y; Xu X; Hu H; Yao H
    Cancer Res; 2022 Feb; 82(4):556-570. PubMed ID: 34965935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals.
    Liang S; Chen Z; Jiang G; Zhou Y; Liu Q; Su Q; Wei W; Du J; Wang H
    Cancer Lett; 2017 Feb; 386():12-23. PubMed ID: 27836733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The targetable nanoparticle BAF312@cRGD-CaP-NP represses tumor growth and angiogenesis by downregulating the S1PR1/P-STAT3/VEGFA axis in triple-negative breast cancer.
    Gong K; Jiao J; Xu C; Dong Y; Li D; He D; Zhao D; Yu J; Sun Y; Zhang W; Bai M; Duan Y
    J Nanobiotechnology; 2021 May; 19(1):165. PubMed ID: 34059068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA TCONS_l2_00002973 correlates with less advanced tumor stage and favorable survival, and also inhibits cancer cells proliferation while enhancing apoptosis in triple-negative breast cancer.
    Yan J; Wang R; Wu Z
    J BUON; 2019; 24(2):535-542. PubMed ID: 31128002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA-mediated regulation of
    Tariq A; Hao Q; Sun Q; Singh DK; Jadaliha M; Zhang Y; Chetlangia N; Ma J; Holton SE; Bhargava R; Lal A; Prasanth SG; Prasanth KV
    RNA; 2020 Feb; 26(2):175-185. PubMed ID: 31690584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
    Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
    Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.